The absolute quantification and percent exon inclusion results (Figure 4c) demonstrate that 8 nM of GLP1 is an optimal dose for reducing exon 17b inclusion into sortilin pre-mRNA in T2DM adipocytes. The gene discussed is GCG; the disease is type 2 diabetes mellitus.